Halberd Corporation (OTCPK: HALB)
Health Care · Biotechnology · US
$0.00
-20.00% today · -65.1% 1Y
Halberd Corporation (OTCPK: HALB) operates in the Biotechnology industry within the Health Care sector. The company is valued at $448.38K and employs 3 people.
Over the last twelve months the share price has lost 65.1%, trading between 0.00 and 0.00.
Tweenvest scores Halberd Corporation across four factors: quality 1/100, value 45/100. Its strongest factor is value.
HALB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $448.38K
- Revenue (TTM)
- $6.94K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 747.30M
- Employees
- 3
- Next earnings
- —
About Halberd Corporation
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
- ISIN
- US4053311092
- Founded
- 2009
- Listed since
- Sep 25, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.